Seeking Alpha

Seeking Alpha Portfolio App for iPad

2,734 people get BAX articles and Market Currents by email alert.

Get email alerts on BAX »

BAX

Baxter International Inc

6/20/2013, 12:27 AM ET

Quote & Headlines Market Currents StockTalk

All
| Earnings
| Dividends
| M&A
| On the move

Tuesday, June 11, 11:36 AM UBS suggests 11 dividend growing stocks to buy for income; each has a dividend yield of at least 2.5%, has increased its payout ratio by more than 5% during the past year, and has positive consensus EPS growth over the next 12 months: WMB, ESV, NUE, JNJ, CAG, KLAC, CSCO, BBT, AAPL, BAX, F. 2 Comments [Quick Ideas]
Tuesday, May 7, 1:54 PM Barclays comes to the defense of Baxter (BAX -3.1%) this afternoon, upping the stock to Overweight on today's weakness. The stock was hit after the drug-maker said Phase III testing of its Gammagard treatment for Alzheimer's disease did not meet its co-primary endpoints. Comment! [Healthcare, On the Move]
Tuesday, May 7, 8:25 AM Baxter International (BAX) slips 2.2% premarket after Phase III testing on its Alzheimer's drug immunoglobulin (IG) - always a long shot - failed to meet its co-primary endpoints. (PR) 1 Comment [Healthcare, On the Move]
Tuesday, May 7, 6:21 AM Baxter International (BAX) declares $0.49/share quarterly dividend, 9% increase from prior dividend of $0.45. Forward yield 2.56%. For shareholders of record June 07. Payable July 01. Ex-div date June 05. (PR) Comment! [Dividends]
Monday, May 6, 7:02 AM Vical (VICL) says the addition of its Vaxfectin adjuvant to Baxter's (BAX) influenza vaccines "substantially increases both antibody and T-cell responses." VICL's VP of vaccine research says seasonal influenza vaccines sometimes underperform in elderly patients — "a good adjuvant could" help, he adds. (PR) Comment! [Healthcare]
Friday, April 26, 3:42 PM Looking for dividend picks, Marketwatch screens the S&P 1,500 for 1) Stock trades at less than a 17x PE 2) Dividend yield 20% or more higher than S&P 500 3) Raised dividend at least 5 times in last 5 years 4) S&P Quality Rank of B+ or better. The winners: T, AVA, BAX, CAH, CAG, ED, JNJ, LG, TAP, RAI, SCG, UVV, WR, XEL. 1 Comment
Thursday, April 18, 9:03 AM More on Baxter (BAX) Q1: net profit -11% to $552M, dragged down by charges related to its purchase of Gambrro, while last year's figures included a tax benefit. Medical-products sales -0.4% to $1.92B, BioScience revenue +4.7% to $1.53B. Expects sales growth of 4% in Q2 and 10% for FY; forecasts EPS of Q2 EPS of $1.12-1.14 vs consensus of $1.14 and 2014 EPS of $4.60-4.70 vs 4.66. (PR) Comment! [Healthcare, Earnings]
Thursday, April 18, 7:03 AM Baxter (BAX): Q1 EPS of $1.05 in-line. Revenue of $3.45B (+2% Y/Y) misses by $0.04B. (PR) Comment! [Earnings, Breaking News, Healthcare]
Thursday, April 18, 12:05 AM Notable earnings before Thursday’s open: ADS, AN, APH, BAX, BBT, BPOP, BTU, BX, CY, DHR, FCS, FCX, FITB, KEY, LDK, MMR, MS, NOK, NUE, OMC, PBCT, PENN, PEP, PM, PPG, SHW, SNA, SON, TSM, TZOO, UNH, UNP, VZ Comment! [Earnings]
Wednesday, April 17, 5:30 PM Notable earnings before Thursday’s open: ADS, AN, APH, BAX, BBT, BPOP, BTU, BX, CY, DHR, FCS, FCX, FITB, KEY, LDK, MMR, MS, NOK, NUE, OMC, PBCT, PENN, PEP, PM, PPG, SHW, SNA, SON, TSM, TZOO, UNH, UNP, VZ Comment! [Earnings]
Thursday, April 4, 4:45 AM The cost of caring for people with dementia is $157-215B a year and could double by 2040, a study from RAND Corp. estimates. The cost of dementia treatment is $109B - above the $102B spent on heart disease and the $77B on cancer - with the other dementia expenses used for long-term day-to-day care. Companies that develop drugs for Alzheimer's disease and other conditions include Pfizer (PFE), Eli Lilly (LLY), J&J (JNJ) and Merck (MRK). 5 Comments [Healthcare]
Friday, March 22, 9:29 AM Halozyme Therapeutics (HALO) +18.6% premarket after the European Medicines Agency approves partner Baxter (BAX) for the use of HALO's HyQvia as replacement therapy for adult patients with primary and secondary immunodeficiencies. Upon receiving marketing authorization from the EC, BAX plans to launch HyQvia in some European countries later this year. Comment! [Healthcare, On the Move]
Tuesday, February 19, 9:35 AM Baxter International Inc. (BAX) declares $0.45/share quarterly dividend, in line with previous. Forward yield 2.64%. For shareholders of record Mar. 08. Payable Apr. 01. Ex-div date Mar. 06. (PR) Comment! [Dividends]
Thursday, January 24, 9:14 AM More on Baxter's (BAX) Q4 results: Forecasts current-quarter EPS of $1.03-$1.05 on 2%-3% sales growth vs. consensus of $1.10 on 4% revenue growth to $3.5B. Forecasts 2013 EPS of $4.60-$4.70 on 10% sales growth vs. consensus $4.84 on 5% revenue growth of $14.8B. Acquires investigational hemophilia compound OBI-1 and related assets from Inspiration BioPharmaceuticals. Comment! [Earnings, Healthcare]
Thursday, January 24, 7:03 AM Baxter (BAX): Q4 EPS of $1.26 in-line. Revenue of $3.8B (+4% Y/Y) beats by $0.08B. (PR) Comment! [Earnings, Breaking News, Healthcare]
Thursday, January 24, 12:05 AM Notable earnings before Thursday’s open: ABC, ALK, ARG, AVT, BAX, BMY, BPOP, CELG, CY, DOV, EQT, ESI, ETN, FCS, GWW, JNS, JVA, KCG, KEY, LMT, LUV, MKC, MMM, MWW, NMM, NOK, ORI, PCP, QSII, RTN, RYN, SWK, TZOO, UAL, UNP, XRX Comment! [Earnings]